Novel biomarkers for prostate cancer: An evidence-based review for use in clinical practice
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Novel biomarkers for prostate cancer: An evidence-based review for use in clinical practice
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF UROLOGY
Volume 24, Issue 5, Pages 352-360
Publisher
Wiley
Online
2017-03-27
DOI
10.1111/iju.13326
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment
- (2016) Scott A. Tomlins et al. EUROPEAN UROLOGY
- New Genetic Markers for Prostate Cancer
- (2016) Michael S. Leapman et al. UROLOGIC CLINICS OF NORTH AMERICA
- Decipher Genomic Classifier Measured on Prostate Biopsy Predicts Metastasis Risk
- (2016) Eric A. Klein et al. UROLOGY
- A Multi-institutional Prospective Trial in the USA Confirms that the 4Kscore Accurately Identifies Men with High-grade Prostate Cancer
- (2015) Dipen J. Parekh et al. EUROPEAN UROLOGY
- A Biopsy-based 17-gene Genomic Prostate Score Predicts Recurrence After Radical Prostatectomy and Adverse Surgical Pathology in a Racially Diverse Population of Men with Clinically Low- and Intermediate-risk Prostate Cancer
- (2015) Jennifer Cullen et al. EUROPEAN UROLOGY
- Novel Biomarker Signature That May Predict Aggressive Disease in African American Men With Prostate Cancer
- (2015) Kosj Yamoah et al. JOURNAL OF CLINICAL ONCOLOGY
- Genomic Classifier Identifies Men With Adverse Pathology After Radical Prostatectomy Who Benefit From Adjuvant Radiation Therapy
- (2015) Robert B. Den et al. JOURNAL OF CLINICAL ONCOLOGY
- The Role of Sarcosine Metabolism in Prostate Cancer Progression
- (2015) Amjad P Khan et al. NEOPLASIA
- A 17-gene Assay to Predict Prostate Cancer Aggressiveness in the Context of Gleason Grade Heterogeneity, Tumor Multifocality, and Biopsy Undersampling
- (2014) Eric A. Klein et al. EUROPEAN UROLOGY
- Circulating Tumor Cell Counts Are Prognostic of Overall Survival in SWOG S0421: A Phase III Trial of Docetaxel With or Without Atrasentan for Metastatic Castration-Resistant Prostate Cancer
- (2014) Amir Goldkorn et al. JOURNAL OF CLINICAL ONCOLOGY
- AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
- (2014) Emmanuel S. Antonarakis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Serum Isoform [−2]proPSA Derivatives Significantly Improve Prediction of Prostate Cancer at Initial Biopsy in a Total PSA Range of 2–10 ng/ml: A Multicentric European Study
- (2013) Massimo Lazzeri et al. EUROPEAN UROLOGY
- Multicenter European External Validation of a Prostate Health Index–based Nomogram for Predicting Prostate Cancer at Extended Biopsy
- (2013) Giovanni Lughezzani et al. EUROPEAN UROLOGY
- Prognostic Utility of Cell Cycle Progression Score in Men With Prostate Cancer After Primary External Beam Radiation Therapy
- (2013) Stephen J. Freedland et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort
- (2012) J Cuzick et al. BRITISH JOURNAL OF CANCER
- Prospective Multicentre Evaluation of PCA3 and TMPRSS2-ERG Gene Fusions as Diagnostic and Prognostic Urinary Biomarkers for Prostate Cancer
- (2012) Gisele H.J.M. Leyten et al. EUROPEAN UROLOGY
- Clinical Utility of an Epigenetic Assay to Detect Occult Prostate Cancer in Histopathologically Negative Biopsies: Results of the MATLOC Study
- (2012) Grant D. Stewart et al. JOURNAL OF UROLOGY
- A Multicenter Study of [-2]Pro-Prostate Specific Antigen Combined With Prostate Specific Antigen and Free Prostate Specific Antigen for Prostate Cancer Detection in the 2.0 to 10.0 ng/ml Prostate Specific Antigen Range
- (2011) William J. Catalona et al. JOURNAL OF UROLOGY
- Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study
- (2011) Jack Cuzick et al. LANCET ONCOLOGY
- Prostate-Specific Antigen (PSA) Isoform p2PSA in Combination with Total PSA and Free PSA Improves Diagnostic Accuracy in Prostate Cancer Detection
- (2010) Flip H. Jansen et al. EUROPEAN UROLOGY
- A Panel of TMPRSS2:ERG Fusion Transcript Markers for Urine-Based Prostate Cancer Detection with High Specificity and Sensitivity
- (2010) Phuong-Nam Nguyen et al. EUROPEAN UROLOGY
- PCA3 Molecular Urine Test for Predicting Repeat Prostate Biopsy Outcome in Populations at Risk: Validation in the Placebo Arm of the Dutasteride REDUCE Trial
- (2010) Sheila M.J. Aubin et al. JOURNAL OF UROLOGY
- Cell-free Tumor DNA in Blood Plasma As a Marker for Circulating Tumor Cells in Prostate Cancer
- (2009) H. Schwarzenbach et al. CLINICAL CANCER RESEARCH
- Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer
- (2008) J. S. de Bono et al. CLINICAL CANCER RESEARCH
- Clinical Utility of the PCA3 Urine Assay in European Men Scheduled for Repeat Biopsy
- (2008) Alexander Haese et al. EUROPEAN UROLOGY
- A Tissue Biomarker Panel Predicting Systemic Progression after PSA Recurrence Post-Definitive Prostate Cancer Therapy
- (2008) Tohru Nakagawa et al. PLoS One
- Mitochondrial Genome Deletion Aids in the Identification of False- and True-Negative Prostate Needle Core Biopsy Specimens
- (2007) Jennifer Maki et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now